Skip to main content
PeptiDream Inc. logo

PeptiDream Inc. — Investor Relations & Filings

Ticker · 4587 ISIN · JP3836750004 T Manufacturing
Open in API
Filings indexed 72 across all filing types
Latest filing 2024-04-01 Share Issue/Capital Cha…
Country JP Japan
Listing T 4587

About PeptiDream Inc.

https://www.peptidream.com/en/

PeptiDream Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutics, primarily macrocyclic peptides. The company utilizes its proprietary Peptide Discovery Platform System (PDPS) to generate and screen extensive libraries of non-standard peptides, aiming to create a new class of innovative medicines. Its business model is centered on global collaborations and licensing agreements with pharmaceutical partners to advance drug discovery programs from hit identification to clinical candidates. PeptiDream's capabilities encompass various preclinical research disciplines, including discovery biology, medicinal chemistry, and pharmacology. Through a wholly-owned subsidiary, the company also markets and sells radiopharmaceutical and radiodiagnostic products.

Recent filings

Filing Released Lang Actions
有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 98% confidence The document is titled "有価証券届出書" (Securities Registration Statement) and is submitted to the Kanto Local Finance Bureau Director on April 1, 2024. The subject of the filing is the issuance of "新株予約権証券" (Stock Acquisition Rights Certificates) for the purpose of granting stock options to directors and employees. This document details the terms of the offering, including issuance price, exercise price, intended use of proceeds (though stated as not for fundraising, but for incentive purposes), and the resulting shareholder structure post-issuance. This structure—a formal filing detailing the terms of a new security issuance, specifically stock options, submitted to a regulatory body (Financial Services Agency/Local Finance Bureau)—is characteristic of a registration statement for a capital-raising or equity incentive event. In the context of the provided definitions, this is a filing related to capital structure changes or financing activities, but the specific nature of a Securities Registration Statement for stock acquisition rights (which often precedes or accompanies a capital change) aligns most closely with a filing related to capital/financing updates or a general regulatory filing. Given the detailed nature of the offering terms for stock acquisition rights, it falls under the scope of 'Capital/Financing Update' (CAP) as it details the issuance of new securities (stock options) which affects capital structure, even if the immediate cash inflow is small or tied to future exercise. It is a comprehensive filing about the issuance terms, not just a brief announcement of a report (RPA/RNS).
2024-04-01 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled with headers indicating it is a '臨時報告書' (Extraordinary Report/Special Report) submitted to the Kanto Local Finance Bureau Director on March 28, 2024. Section 1 explicitly states the reason for filing is due to resolutions passed at the Annual General Meeting (AGM) held on March 27, 2024, citing Japanese financial regulations (FIEA Article 24-5(4)). Section 2 details the resolutions, specifically the election of three directors. This structure—reporting the results of a shareholder meeting's resolutions—perfectly matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the core content is the official voting outcome, not the AGM presentation materials (AGM-R) or proxy solicitation (PSI).
2024-03-28 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is extremely short (615 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning '有価証券報告書' (Annual Securities Report, equivalent to 10-K in structure but filed under Japanese law) and a confirmation statement ('確認書') signed by the CEO and CFO regarding the '記載内容が金融商品取引法令に基づき適正に記載されていること' (that the contents are appropriately stated based on the Financial Instruments and Exchange Act). This document is a formal confirmation/attestation regarding the accuracy of the full Annual Securities Report (which would be the 10-K equivalent). Since this is a short confirmation document related to the annual filing, and not the full report itself, it fits best under the general 'Audit Report / Information' (AR) category, which covers attestations and regulatory stress tests, or potentially 'Regulatory Filings' (RNS) as a fallback. Given the specific nature of confirming the accuracy of the annual filing, AR is a stronger fit than the general RNS, although it is not a full audit report. However, looking closely at the definitions, 'AR' is for 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests'. This is a management attestation on the accuracy of the 10-K equivalent. Since there is no specific code for a 'Management Attestation on Annual Report Accuracy', and it is not the full 10-K, the most appropriate classification among the provided options for a short, specific regulatory confirmation related to annual financials is 'AR' or the fallback 'RNS'. Given the context of confirming the '有価証券報告書' (Annual Securities Report), which is the Japanese equivalent of the 10-K, this confirmation document is closely related to the audit/attestation process. I will classify it as AR, as it is a formal confirmation related to the annual financial statement accuracy, which is often grouped with audit information. FY 2023
2024-03-28 Japanese
内部統制報告書－第18期(2023/01/01－2023/12/31)
Governance Information Classification · 100% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法). The content discusses the framework, scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting as of the fiscal year-end (2023年12月31日). This structure is characteristic of an annual internal control report, which is often filed alongside the 10-K or as a standalone report in Japan. Given the specific focus on internal control assessment, it aligns best with the 'Audit Report / Information' category (AR), as it deals with the assurance and structure surrounding financial reporting, although it is distinct from a standard external audit opinion. However, since the document is a formal, comprehensive report detailing the internal control framework and assessment results, and not just a brief announcement, it is classified as a formal report. In the provided schema, 'AR' covers standalone audit reports and applied accounting principles. While this is an internal control report, it is the closest fit for a comprehensive, non-annual-report financial assurance document. If a specific 'Internal Control Report' code existed, it would be used, but 'AR' is the most appropriate proxy for formal assurance/control documentation.
2024-03-28 Japanese
有価証券報告書－第18期(2023/01/01－2023/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It includes detailed financial statements, business indicators, and management information for the fiscal year ending December 31, 2023. The document structure, including the header with the filing date (2024-03-28) and the fiscal period, confirms it is the comprehensive annual financial filing. FY 2023
2024-03-28 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-8, Paragraph 1. It is a mandatory regulatory filing in Japan that accompanies a Quarterly Report (Shihanki Hokokusho) to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law to accompany financial reports and does not fit into the other categories like 'IR' (which would be the report itself) or 'RPA' (as it is a formal legal confirmation document rather than just an announcement), it is best classified as a Regulatory Filing.
2023-11-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.